Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CRY

CryoLife (CRY) Stock Price, News & Analysis

CryoLife logo

About CryoLife Stock (NYSE:CRY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$17.19
$21.72
52-Week Range
N/A
Volume
7,792 shs
Average Volume
198,221 shs
Market Capitalization
$703.22 million
P/E Ratio
596.20
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRY Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.tc pixel
Artivion price target raised to $35 from $32 at Lake Street
Artivion (AORT) Receives a Buy from Lake Street
See More Headlines

CRY Stock Analysis - Frequently Asked Questions

CryoLife, Inc. (NYSE:CRY) released its quarterly earnings data on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.22. The medical equipment provider earned $72.21 million during the quarter, compared to analysts' expectations of $72.90 million. CryoLife had a net margin of 0.63% and a trailing twelve-month return on equity of 4.24%.

CryoLife subsidiaries include JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX).

Company Calendar

Last Earnings
11/04/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:CRY
CIK
784199
Employees
1,200
Year Founded
1984

Profitability

EPS (Trailing Twelve Months)
$0.03
Trailing P/E Ratio
596.20
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.68 million
Net Margins
0.63%
Pretax Margin
0.41%
Return on Equity
4.24%
Return on Assets
1.63%

Debt

Debt-to-Equity Ratio
0.99
Current Ratio
4.21
Quick Ratio
2.93

Sales & Book Value

Annual Sales
$253.23 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
23.30
Book Value
$8.46 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
39,330,000
Free Float
37,560,000
Market Cap
$703.22 million
Optionable
Optionable
Beta
1.53

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:CRY) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners